Physician profile
Nancy Arnold
NPI 1730156258
$3,417.90
in general payments reported to CMS, 2019-2025
33 companies · $468 in 2025
The $468 reported for 2025 was more than what 82% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $695 · 2022: $1,006 · 2023: $605 · 2024: $644 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,623 · Education: $93.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,623.49 |
| Education | $93.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $407.50 | 2021-2025 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $355.99 | 2021-2025 | |
| Myovant Sciences INC. | $321.33 | 2021-2022 | |
| Astellas Pharma US INC | $234.92 | 2022-2025 | Veozah |
| Abbvie INC. | $232.91 | 2021-2025 | |
| Exeltis, USA INC. | $230.95 | 2021-2025 | Slynd |
| Evofem Biosciences, INC. | $216.23 | 2021-2025 | Phexxi, Solosec, Phexx |
| Lilly USA, LLC | $191.08 | 2022-2025 | Zepbound |
| Hologic Sales and Service, LLC | $140.52 | 2022-2024 | Aptima, Thinprep 2000 Processor, Third Wave |
| Novo Nordisk INC | $118.39 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Therapeuticsmd, INC. | $115.25 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $102.52 | 2023-2024 | Myfembree |
| Radius Health, INC. | $101.57 | 2021-2025 | Tymlos |
| Alexion Pharmaceuticals, INC. | $79.43 | 2024 | Strensiq |
| Agile Therapeutics, INC. | $69.66 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $63.19 | 2024 | |
| Organon LLC | $56.90 | 2022-2024 | Nexplanon |
| Mylan Pharmaceuticals INC. | $52.32 | 2021-2022 | |
| Scynexis, INC. | $35.19 | 2022 | |
| Millicent US INC | $34.35 | 2025 | Femlyv |
| Optumhealth Care Solutions, LLC | $33.68 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Virtus Pharmaceuticals LLC | $31.55 | 2021 | |
| Coopersurgical, INC. | $24.90 | 2022 | |
| Aspira Women'S Health INC | $23.48 | 2022 | |
| Lupin INC. | $20.47 | 2021 | |
| Impel Pharmaceuticals INC. | $19.01 | 2022 | |
| Minerva Surgical, INC | $17.67 | 2023 | |
| Daiichi Sankyo INC. | $17.25 | 2021 | |
| Merck Sharp & Dohme LLC | $17.23 | 2021 | |
| Exact Sciences Corporation | $15.12 | 2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $13.35 | 2023 | Balcoltra |
| Currax Pharmaceuticals LLC | $12.01 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.